4.4 Article

Unplanned intensive care unit readmission after surgical treatment in patients with newly diagnosed glioblastoma - forfeiture of surgically achieved advantages?

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Perioperative red blood cell transfusion is associated with poor functional outcome and overall survival in patients with newly diagnosed glioblastoma

Matthias Schneider et al.

Summary: Perioperative RBC transfusion is significantly associated with poorer survival outcomes in newly diagnosed glioblastoma patients, along with factors such as age, extent of resection, and MGMT status. Adhering to evidence-based transfusion guidelines may help reduce transfusion rates and potentially improve patient survival in this population.

NEUROSURGICAL REVIEW (2022)

Article Clinical Neurology

Implementation of the No ICU - Unless approach in postoperative neurosurgical management in times of COVID-19

Lina-Elisabeth Qasem et al.

Summary: This study compared the impact of a No ICU - Unless strategy with routine ICU management on patients undergoing elective craniotomy. It found no significant difference in complication rates and surgical outcomes between the two strategies. The No ICU strategy may represent a potential approach to prevent overutilization of ICU resources while ensuring sufficient postoperative care.

NEUROSURGICAL REVIEW (2022)

Article Oncology

Electrolyte and renal disorders in patients with newly diagnosed glioblastoma

Daniela Pierscianek et al.

Summary: This retrospective study found that hypochloremia is an independent prognostic factor for glioblastoma patients, associated with poorer survival rates.

FUTURE ONCOLOGY (2021)

Article Oncology

Red blood cell distribution width to platelet ratio substantiates preoperative survival prediction in patients with newly-diagnosed glioblastoma

Matthias Schneider et al.

Summary: In the study, the preoperative routine laboratory values were analyzed for their prognostic significance in newly-diagnosed glioblastoma patients. The RDW to platelet count ratio (RPR) was found to be a novel prognostic inflammatory marker that could contribute to a personalized medicine approach in the course of preoperative routine laboratory examinations.

JOURNAL OF NEURO-ONCOLOGY (2021)

Article Clinical Neurology

The SHORT Score for Preoperative Assessment of the Risk for Short -Term Survival in Glioblastoma

Daniela Pierscianek et al.

WORLD NEUROSURGERY (2020)

Article Clinical Neurology

Dexamethasone in Patients with Spontaneous Intracerebral Hemorrhage: An Updated Meta-Analysis

Stephanie Wintzer et al.

CEREBROVASCULAR DISEASES (2020)

Article Endocrinology & Metabolism

Controversial roles for dexamethasone in glioblastoma - Opportunities for novel vascular targeting therapies

Daniel Dubinski et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2019)

Article Oncology

Surgery for temporal glioblastoma: lobectomy outranks oncosurgical-based gross-total resection

Matthias Schneider et al.

JOURNAL OF NEURO-ONCOLOGY (2019)

Article Clinical Neurology

Management of Glioblastoma, Present and Future

Nancy Ann Oberheim Bush et al.

WORLD NEUROSURGERY (2019)

Article Medicine, Research & Experimental

Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma

Alexander Scholz et al.

EMBO MOLECULAR MEDICINE (2016)

Article Clinical Neurology

Corticosteroids compromise survival in glioblastoma

Kenneth L. Pitter et al.

BRAIN (2016)

Article Multidisciplinary Sciences

Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages

Teresa E. Peterson et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Otorhinolaryngology

Dexamethasone and Risk of Bleeding in Children Undergoing Tonsillectomy

Sanjay Mahant et al.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2014)

Editorial Material Clinical Neurology

Routine Intensive Care Unit-Level Care After Elective Craniotomy: Time to Rethink

Nils Hecht et al.

WORLD NEUROSURGERY (2014)

Article Clinical Neurology

Postoperative Intensive Care Unit Requirements After Elective Craniotomy

Brian W. Hanak et al.

WORLD NEUROSURGERY (2014)

Article Medicine, General & Internal

Use of Glucocorticoids and Risk of Venous Thromboembolism A Nationwide Population-Based Case-Control Study

Sigrun A. Johannesdottir et al.

JAMA INTERNAL MEDICINE (2013)

Review Pharmacology & Pharmacy

Corticosteroid-related central nervous system side effects

Miriam Ciriaco et al.

JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2013)

Article Anesthesiology

Do Patients Still Require Admission to an Intensive Care Unit After Elective Craniotomy for Brain Surgery?

Ossam Rhondali et al.

JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY (2011)

Article Clinical Neurology

Independent association of extent of resection with survival in patients with malignant brain astrocytoma

Matthew J. McGirt et al.

JOURNAL OF NEUROSURGERY (2009)

Article Oncology

Delay in radiotherapy shortens survival in patients with high grade glioma

Chris Irwin et al.

JOURNAL OF NEURO-ONCOLOGY (2007)

Article Endocrinology & Metabolism

Effects of short-term glucocorticoids on cardiovascular biomarkers

DJ Brotman et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)

Article Biochemistry & Molecular Biology

Effects of dexamethasone on K+-evoked glutamate release from rat hippocampal slices

N Ioannou et al.

NEUROCHEMICAL RESEARCH (2003)